GLOBUS MEDICAL INC - A (GMED) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:GMED - US3795772082 - Common Stock
91.96 USD
-1.02 (-1.1%)
91.96 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 77% to GMED. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 106. This target is 15.26% above the current price.
- GMED was analyzed by 21 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about GMED.
- In the previous month the buy percentage consensus was at a similar level.
- GMED was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-09 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-01-08 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-12-17 | Freedom Capital Markets | Initiate | Hold |
| 2025-12-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-18 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-11-10 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-07 | Truist Securities | Upgrade | Hold -> Buy |
| 2025-11-07 | B of A Securities | Upgrade | Neutral -> Buy |
| 2025-10-28 | Stifel | Reiterate | Hold |
| 2025-08-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-22 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-07-21 | Needham | Reiterate | Hold -> Hold |
| 2025-07-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-27 | BTIG | Downgrade | Buy -> Neutral |
| 2025-05-27 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2025-05-12 | Truist Securities | Maintains | Hold -> Hold |
| 2025-05-09 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-11 | Truist Securities | Maintains | Hold -> Hold |
| 2025-03-18 | Needham | Reiterate | Hold -> Hold |
| 2025-03-18 | Truist Securities | Maintains | Hold -> Hold |
| 2025-02-24 | Citizens Capital Markets | Reiterate | Market Perform -> Market Perform |
| 2025-02-24 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-21 | Needham | Reiterate | Hold -> Hold |
| 2025-02-21 | Stifel | Maintains | Buy -> Buy |
| 2025-02-21 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-06 | Needham | Reiterate | Hold -> Hold |
GLOBUS MEDICAL INC - A / GMED FAQ
What is the average price target for GLOBUS MEDICAL INC - A (GMED) stock?
21 analysts have analysed GMED and the average price target is 106 USD. This implies a price increase of 15.26% is expected in the next year compared to the current price of 91.96.
How do analysts rate GLOBUS MEDICAL INC - A (GMED)?
The consensus rating for GLOBUS MEDICAL INC - A (GMED) is 77.1429 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for GMED stock?
The number of analysts covering GLOBUS MEDICAL INC - A (GMED) is 21.